UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

___________________

 

FORM 8-K

___________________

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

November 13, 2024

___________________

 

Catheter Precision, Inc.

(Exact name of registrant as specified in its charter)

___________________

 

Delaware

 

001-38677

 

38-3661826

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

1670 Highway 160 West

Suite 205

Fort Mill, SC 29708

(Address of principal executive offices, including zip code)

 

(973) 691-2000

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report.)

___________________

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

VTAK

NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

On November 13, 2024, Catheter Precision, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2024.  The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.  The information in this current report shall not be incorporated by reference into any registration statement or other document filed with the Securities and Exchange Commission, whether filed before or after the date hereof regardless of any general incorporation language in any such filing, unless the registrant expressly sets forth in such filing that such information is to be considered “filed” or incorporated by reference therein.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit 

 

Description

 

 

 

99.1

 

Press Release Issued on November 13, 2024

 

 

 

104

 

Cover Page Interactive Data File (formatted as inline XBRL)

 

 
2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

CATHETER PRECISION, INC.

 

 

 

 

 

 

Date:

November 14, 2024

By:

/s/ Margrit Thomassen

 

 

 

 

Margrit Thomassen

 

 

 

 

Interim Chief Financial Officer

 

 

 
3

 

nullv3.24.3
Cover
Nov. 13, 2024
Cover [Abstract]  
Entity Registrant Name Catheter Precision, Inc.
Entity Central Index Key 0001716621
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company false
Document Period End Date Nov. 13, 2024
Entity File Number 001-38677
Entity Incorporation State Country Code DE
Entity Tax Identification Number 38-3661826
Entity Address Address Line 1 1670 Highway 160 West
Entity Address Address Line 2 Suite 205
Entity Address City Or Town Fort Mill,
Entity Address State Or Province SC
Entity Address Postal Zip Code 29708
City Area Code 973
Local Phone Number 691-2000
Security 12b Title Common Stock, par value $0.0001 per share
Trading Symbol VTAK
Security Exchange Name NYSE
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Catheter Precision (AMEX:VTAK)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Catheter Precision.
Catheter Precision (AMEX:VTAK)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Catheter Precision.